Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,146 | 65,675 | 74,103 | 90,438 | 99,309 |
| Receivables | 3,563 | 2,434 | 3,543 | 1,519 | 1,409 |
| Other current assets | 5,338 | 5,122 | 5,639 | 5,967 | 2,633 |
| TOTAL | $69,047 | $73,231 | $83,285 | $97,924 | $103,351 |
| Non-Current Assets | |||||
| PPE Net | 3,702 | 2,299 | 2,407 | 2,428 | 2,524 |
| Intangibles | 43,761 | 43,814 | 43,867 | 36,402 | 36,402 |
| Other Non-Current Assets | 1,694 | 1,693 | 1,692 | 158 | 157 |
| TOTAL | $49,157 | $47,806 | $47,966 | $38,988 | $39,083 |
| Total Assets | $118,204 | $121,037 | $131,251 | $136,912 | $142,434 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,065 | 1,500 | 332 | 9,827 | 6,516 |
| Accrued Expenses | 12,052 | 9,742 | 9,212 | N/A | N/A |
| Other current liabilities | 312 | 126 | 185 | 115 | 115 |
| TOTAL | $13,429 | $11,368 | $9,729 | $9,942 | $6,631 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 19,757 | 31,192 | 19,662 | 18,974 | 19,186 |
| TOTAL | $30,937 | $31,174 | $30,861 | $30,306 | $30,518 |
| Total Liabilities | $44,366 | $42,542 | $40,590 | $40,248 | $37,149 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,985 | 69,946 | 69,946 | 69,806 | 69,685 |
| Common Shares | 91 | 91 | 91 | 91 | 91 |
| Retained earnings | -519,672 | -514,034 | -501,379 | -494,232 | -484,218 |
| Other shareholders' equity | 361 | 351 | 438 | 259 | 259 |
| TOTAL | $73,838 | $78,495 | $90,661 | $96,664 | $105,285 |
| Total Liabilities And Equity | $118,204 | $121,037 | $131,251 | $136,912 | $142,434 |